NCDC Monitoring New COVID-19 Subvariants,Implements Testing Strategy Testing Planned in Four States
The Nigeria Centre for Disease Control and Prevention (NCDC) is actively monitoring two new subvariants of the Omicron variant, EG.5 and BA.2.86, both of which share symptoms with other COVID-19 variants.
The NCDC is closely overseeing these subvariants through its COVID-19 Technical Working Group, spanning from local to global levels.
Their influenza sentinel surveillance sites provide insights into COVID-19 prevalence among those with respiratory illnesses.
Emphasizing the value of verified information and preventive measures, the NCDC urges the public to stay informed and cautious. While no significant COVID-19 trends have been noted in specific patient groups, the agency, in collaboration with partners, is gearing up for an advanced testing initiative across four states.
This initiative aims to gather detailed data on circulating variants, aided by the distribution of rapid diagnostic kits.
While reinforcing existing preventive measures such as hand hygiene, testing, vaccination, and mask usage, the NCDC advises against unnecessary panic.
The agency highlights that COVID-19 primarily affects high-risk individuals, especially the elderly and those with chronic illnesses.
The EG.5 subvariant, categorized as a “variant of interest” by the WHO, is present in 51 countries with low global risk. Its symptoms resemble those of other COVID-19 variants.
While EG.5 has been identified in Africa, Nigeria hasn’t reported cases. Although BA.2 has been detected in Nigeria, the BA.2.86 variant hasn’t been reported.
In essence, the NCDC’s proactive approach underscores its commitment to public health. By diligently monitoring and strategically testing, they aim to provide essential information for navigating the evolving COVID-19 situation.